Medartis H1 FY26 core net profit turns to CHF 6.8 million; net sales rise 30.7% to CHF 160.8 million

• Medartis posted H1 net sales of CHF 160.8 million, up 30.7%.
• Core EBITDA rose to CHF 28.8 million; core margin widened 0.2 percentage points to 18%.
• Net profit turned to CHF 4.9 million from a loss; CEO Matthias Schupp cited progress in Latin America, US distribution, TOUCH rollout.
• Management lifted 2026 guidance to 17%-19% organic core sales growth, targeting a core EBITDA margin in the high teens.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medartis Holding AG published the original content used to generate this news brief via EQS News (Ref. ID: adhoc_2384318_en) on August 18, 2026, and is solely responsible for the information contained therein.